17103167

Source:http://linkedlifedata.com/resource/pubmed/id/17103167

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007131, umls-concept:C0031268, umls-concept:C0031809, umls-concept:C0032743, umls-concept:C0046056, umls-concept:C0087111, umls-concept:C0441771, umls-concept:C0445204, umls-concept:C0600558, umls-concept:C0681840, umls-concept:C0871261, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	4
pubmed:dateCreated	2007-3-15
pubmed:abstractText	The aim of this study was to evaluate FDG-PET for assessment of therapy response and for prediction of patient outcome after neo-adjuvant radio-chemotherapy (NARCT) of advanced non-small cell lung cancer (NSCLC).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101140988
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyglucose F18, http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1619-7070
pubmed:author	pubmed-author:BaresRolandR, pubmed-author:BudachWilfriedW, pubmed-author:EschmannSusanne MartinaSM, pubmed-author:FriedelGodehardG, pubmed-author:HehrThomasT, pubmed-author:LangenHeinz-JakobHJ, pubmed-author:PaulsenFrankF, pubmed-author:ReimoldMatthiasM
pubmed:issnType	Print
pubmed:volume	34
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	463-71
pubmed:meshHeading	pubmed-meshheading:17103167-Adult, pubmed-meshheading:17103167-Aged, pubmed-meshheading:17103167-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:17103167-Chemotherapy, Adjuvant, pubmed-meshheading:17103167-Female, pubmed-meshheading:17103167-Fluorodeoxyglucose F18, pubmed-meshheading:17103167-Germany, pubmed-meshheading:17103167-Humans, pubmed-meshheading:17103167-Lung Neoplasms, pubmed-meshheading:17103167-Lymphatic Metastasis, pubmed-meshheading:17103167-Male, pubmed-meshheading:17103167-Middle Aged, pubmed-meshheading:17103167-Neoadjuvant Therapy, pubmed-meshheading:17103167-Neoplasm Staging, pubmed-meshheading:17103167-Positron-Emission Tomography, pubmed-meshheading:17103167-Preoperative Care, pubmed-meshheading:17103167-Prevalence, pubmed-meshheading:17103167-Prognosis, pubmed-meshheading:17103167-Radiopharmaceuticals, pubmed-meshheading:17103167-Radiotherapy, Adjuvant, pubmed-meshheading:17103167-Risk Assessment, pubmed-meshheading:17103167-Risk Factors, pubmed-meshheading:17103167-Survival Analysis, pubmed-meshheading:17103167-Survival Rate, pubmed-meshheading:17103167-Treatment Outcome
pubmed:year	2007
pubmed:articleTitle	18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer.
pubmed:affiliation	Department of Nuclear Medicine, University of Tübingen, Otfried-Mueller-Strasse 14, 72076, Tübingen, Germany. susanne-martina.eschmann@med.uni-tuebingen.de
pubmed:publicationType	Journal Article, Controlled Clinical Trial